- Home
- SPRY vs GRDN Comparison
SPRY vs GRDN Comparison
Compare SPRY & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- GRDN
- Stock Information
- Founded
- SPRY 2015
- GRDN 2004
- Country
- SPRY United States
- GRDN United States
- Employees
- SPRY N/A
- GRDN N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- GRDN Retail-Drug Stores and Proprietary Stores
- Sector
- SPRY Health Care
- GRDN Consumer Staples
- Exchange
- SPRY Nasdaq
- GRDN Nasdaq
- Market Cap
- SPRY 1.1B
- GRDN 1.3B
- IPO Year
- SPRY N/A
- GRDN 2024
- Fundamental
- Price
- SPRY $11.24
- GRDN $19.62
- Analyst Decision
- SPRY Strong Buy
- GRDN Strong Buy
- Analyst Count
- SPRY 4
- GRDN 2
- Target Price
- SPRY $26.00
- GRDN $22.50
- AVG Volume (30 Days)
- SPRY 1.2M
- GRDN 53.5K
- Earning Date
- SPRY 03-20-2025
- GRDN 03-04-2025
- Dividend Yield
- SPRY N/A
- GRDN N/A
- EPS Growth
- SPRY N/A
- GRDN N/A
- EPS
- SPRY N/A
- GRDN N/A
- Revenue
- SPRY $2,568,000.00
- GRDN $1,170,907,000.00
- Revenue This Year
- SPRY $68,783.34
- GRDN $18.05
- Revenue Next Year
- SPRY $503.87
- GRDN $9.55
- P/E Ratio
- SPRY N/A
- GRDN N/A
- Revenue Growth
- SPRY 8460.00
- GRDN 16.86
- 52 Week Low
- SPRY $7.55
- GRDN $14.16
- 52 Week High
- SPRY $18.51
- GRDN $25.74
- Technical
- Relative Strength Index (RSI)
- SPRY 37.72
- GRDN N/A
- Support Level
- SPRY $11.58
- GRDN N/A
- Resistance Level
- SPRY $12.43
- GRDN N/A
- Average True Range (ATR)
- SPRY 0.72
- GRDN 0.00
- MACD
- SPRY -0.14
- GRDN 0.00
- Stochastic Oscillator
- SPRY 0.53
- GRDN 0.00
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.